longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Bolt Biotherapeutics

BOLT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
  • Why Is Penny Stock Bolt Biotherapeutics (BOLT) Up 62% Today?

    Tip Ranks·Oct 23, 2026 at 06:19 PM
    BOLT+49.64%
  • 12 Health Care Stocks Moving In Friday's Intraday Session

    benzinga_article·Oct 23, 2026 at 05:05 PM
    AARD-64.81%BOLT+49.64%
  • Bolt Biotherapeutics soars 57% during regular trading

    Market Movers·Oct 23, 2026 at 01:55 PM
    BOLT+49.64%
  • Bolt, Stellantis plan autonomous driving experiment in Greater Paris from 2028

    CNA·Oct 23, 2026 at 10:38 AM
    BOLT+49.64%STLA-4.92%
  • Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications | BOLT Stock News

    StockTitan·Oct 23, 2026 at 05:08 AM
    BOLT+49.64%
  • Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01

    PUBT·Sep 21, 2026 at 10:04 PM
    BOLT+49.64%
  • Resource Stocks Deliver Strong Earnings Amid Broad Market Restructuring

    Global Report·Sep 15, 2026 at 10:12 AM
    NTR+0.94%IAG-0.97%
  • Bolt Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.

    benzinga_article·Aug 12, 2026 at 03:17 PM
    BOLT+49.64%
  • Bolt Biotherapeutics rugi bersih Q2 FY26 menyempit 9,82% menjadi USD 7,72 juta

    PUBT·Aug 11, 2026 at 08:12 PM
    BOLT+49.64%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy